Event Brief
Mar 30, 2026 at 7:05 PM ET
Eli Lilly signs $2bn AI drug deal with Hong Kong firm
By The BriefBrief
Eli Lilly partners with a Hong Kong biotech for AI-driven drug development in a $2 billion deal.
WHO: Eli Lilly
WHAT: signed a $2 billion deal for AI drug development
WHEN: Mar 30, 2026 at 2:31 PM ET
WHERE: Hong Kong
WHY: to enhance drug development capabilities using AI technology
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21414 of 21414
Same format. Every time.
Continue reading — sign in or create a free account with
